In this study, researchers sought to determine the impact of the FDA’s Accelerated Approval pathway among patients with solid tumors.
The FDA has approved Exdensur (depemokimab-ulaa) as an add-on maintenance treatment for people with severe asthma.
The FDA has proposed adding bemotrizinol, a new sunscreen ingredient, to the U.S. approval list, which could expand consumer ...
The U.S. Food and Drug Administration (FDA) has approved Enhertu (fam-trastuzumab deruxtecan-nxki) in combination with ...
MedPage Today on MSN
Myeloma Combination Cuts the Line for FDA Approval After Strong ASH Results
Under a program designed to accelerate the approval of products that could address key national priorities, the FDA awarded a ...
First FDA approved treatment in 30+ years for more than 2 million Americans with PSVT Novel nasal spray designed to rapidly ...
3d
US approves oral drug for adults with rare type of lung cancer after early clinical trials globally
Sevabertinib showed promise in early trials for non-squamous non-small-cell lung cancer with HER2 mutations. Read more at ...
The FDA’s effort to curb high drug costs by accelerating approvals of cheaper medicines similar to expensive biologics will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback